Navigation Links
An individualized approach to breast cancer treatment
Date:1/26/2009

Not all breast cancers are the same, and not all will have fatal consequences. But because clinicians find it difficult to accurately determine which tumors will metastasize, many patients do not receive the therapy fits their disease.

Tel Aviv University has now refined breast cancer identification so that each course of treatment is as individual as the woman being treated.

The new approach based on a combination of MRI and ultrasound is able to measure the metabolism rates of cancer cells. The approach helps determine at an earlier stage than ever before which cells are metastasizing, and how they should be treated.

The method, expected to start clinical trials in 2010, is currently being researched in Israel hospitals.

Leading the Way to a New Field of Medicine

"We have developed a non-intrusive way of studying the metabolism of breast cancer in real time," says Dr. Ilan Tsarfaty, a lead researcher from TAU's Sackler Faculty of Medicine. "It's an invaluable tool. By the time results are in from a traditional biopsy, the cancer can already be radically different. But using our technique, we can map the tumor and its borders and determine with high levels of certainty right away which patients should be treated aggressively."

The research falls in a new field called "translational and personalized medicine", and Dr. Tsarfaty says it has the potential to save thousands of lives. Papers describing his methodologies were published recently in the journals Cancer Research and Neoplasia.

"Current breast cancer treatments are not tailored to individual patients," Dr. Tsarfaty says. "Our approach to profiling individual tumors will not only help save lives today, it will provide the basic research for developing cancer drugs of the future," he says.

An Application to Other Cancers

The new research can be applied to all solid tumors, including those resulting from lung and brain cancer, and could be used to respond to a wide spectrum of neurodegenerative diseases, such as Alzheimer's, Dr. Tsarfaty reports.

Dr. Tsarfaty's MRI-and-ultrasound-imaging application monitors the metabolic changes that occur during cancer metastasis. Increased blood flow (which can be sensed by ultrasound) and an increase of oxygen consumption (measured with an MRI) can indicate cancer metastasis with unprecedented levels of sensitivity.

Normally scientists look for structural changes in the body, such as the presence of a tumor. But with their new methods, Dr. Tsasfaty and his team which includes his wife, a radiologist are actually able to "see" cancer metastasis within a small group of cells long before the cancer spreads to other organs in the body.

Earlier Detection, Earlier Treatment

"Today, clinicians only diagnose cancer when they see a tumor several millimeters in size. But our diagnosis can be derived from observing only a few cells, and looks specifically at the activation levels of a protein called Met. Activated Met is an oncogen," he says. "If the tumor cells show activation of Met, we can design personalized medicine to treat a specific kind of breast cancer."

At Tel Aviv University, Dr. Tsarfaty is now working to establish a Molecular Imaging Center one of the first to encompass a multi-discipline approach to cancer imaging and treatment. The Breast Cancer Research Foundation of America supports his research.


'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Related medicine news :

1. Molecular imaging enables earlier, individualized treatment of thyroid cancer
2. Every patient is unique: Individualized therapies for non-Hodgkins lymphoma
3. CMS Staffing Announces a its New and Revolutionary Consultative Approach With Clients
4. Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management
5. Heartworm CD by Merial Offers Unique Approach to Managing this Deadly Condition
6. After Founding Meeting in St. Louis ... Labor Unions Vow Stepped Up Pressure on Congress to Support Medicare for All Approach to Healthcare Reform
7. Frost & Sullivan Recognizes Neotropixs Approach to the Treatment of Small Cell Lung Cancer and Neuroendocrine Cancers
8. U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach
9. Nationally-Recognized Pancreatic Cancer Surgeon Develops Unique Team Approach to Improve Patient Outcomes
10. A New, Smart Approach to Brain and Spine Surgery
11. Thrombectomy Device Market to Approach $900 Million by 2013, According to Millennium Research Group
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
An individualized approach to breast cancer treatment
(Date:9/20/2017)... ... , ... “The Trials I Face to Receive God’s Grace”: a mesmerizing ... and goals to better one’s life through God. “The Trials I Face to Receive ... the wrong places, found a love for writing. Green feels that expressing his feelings ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... ... asked at a gathering of executive marketers this week about the value of ... , "Everything that has happened in business has brought us to the ...
(Date:9/20/2017)... ... ... “They Sang At Her Funeral”: a tale of murder that will bring a church ... “They Sang At Her Funeral” is the creation of published author, Annalise Harold, an ... and twelve grandchildren. Before becoming a writer, Annalise had the opportunity to relocate often ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, a leading ... Denise Flannery, to its strategic advisory and client development team. , In ... with clients across different industries to develop and implement market-justified strategies, modernize and ...
(Date:9/19/2017)... , ... September 19, 2017 ... ... that Scott McFarland has joined its executive team as the President of ... innovative value-based care management systems and contact centers. , “Scott is a ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... IRVING, Texas , Sept. 7, 2017 /PRNewswire/ ... molecular science focused on fulfilling the promise of ... that further validate the benefits of its molecular ... Each study utilized comprehensive genomic profiling plus (CGP+) ... each individual patient,s tumor on a molecular level, ...
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... 2017  Robert G. Szewc, M.D., is recognized by ... recognition of his contributions to the Medical field.      ... at the practice of Kidney and Hypertension Specialists, which ... hypertension solutions. He has worked in this position since ... as well as expertise in kidneys, hypertension, chronic disease ...
Breaking Medicine Technology: